{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/66d0580dce37332045241916/66f18ef36668a6dc741b03ed?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Ep 2: Cresset Group's Mutlu Dogruel on AI Drug Discovery","description":"<p>We see Cresset Drug Discovery's very own VP of Artificial Intelligence Mutlu Dogruel discuss all things AI, Drug Discovery and AGI. </p><p><br></p><p>Mutlu gives us a detailed overview of how AI is used in Drug Discovery, the dangers associated with this, mitigating them and how his team at Cresset are doing these very things. </p><p><br></p><p>Then, the topic of Artifificial General Intelligence (AGI) is covered, with some interesting thought experiments.</p><p><br></p><p>This podcast is powered by Strativ Group, talent solutions specialists in AI. </p><p><br></p><p>If you'd like to get involved in our Beyond the Model podcast series, reach out to our host Kieran at k.haynes@strativgroup.com.</p>","author_name":"Dan Wilkinson"}